1. Lemon SM, Walker CM. Hepatitis A Virus and Hepatitis E Virus: Emerging and Re-Emerging Enterically Transmitted Hepatitis Viruses. Cold Spring Harb Perspect Med. 2019; 9: a031823.
2. Velavan TP, Pallerla SR, Johne R, et al. Hepatitis E: An update on One Health and clinical medicine. Liver Int. 2021; 41:1462-1473.
3. Krugman S, Giles JP, Hammond J. Infectious hepatitis. Evidence for two distinctive clinical, epidemiological, and immunological types of infection. JAMA 1967;200:365-73.
4. Feinstone SM, Kapikian AZ, Purcel RH. Hepatitis A: Detection by immune electron microscopy of a virus-like antigen associated with acute illness. Science 1973; 182: 1026-8.
5. Khuroo MS. 1980. Study of an epidemic of non-A, non-B hepatitis: Possibility of another human hepatitis virus distinct from post-transfusion non-A, non-B type. AmJ Med 68: 818–824.
6. Balayan MS, Andjaparidze AG, Savinskaya SS, et al. Evidence for a virus in non-A, non-B hepatitis transmitted via the fecal-oral route. Intervirology. 1983; 20: 23–31.
7. Tam AW, Smith MM, Guera ME, et al. Hepatitis E virus:molecular cloning and sequencing of the full-length viral genome. Virology. 1991; 185: 120-31.
8. Gotlieb N, Moradpour D, Shouval D. Hepatitis A and E – Differences and commonalities. J Hepatol. 2020; 72: 578-580.
9. Smith DB, Simmonds P. Classification and Genomic Diversity of Enterically Transmitted Hepatitis Viruses. Cold Spring Harb Perspect Med. 2018; 8: a031880.
10. Feng Z, Hirai-Yuki A, McKnight KL, Lemon SM. Naked Viruses That Aren’t Always Naked: Quasi-Enveloped Agents of Acute Hepatitis. Annu Rev Virol. 2014; 1: 539-60.
11. Drexler JF, Corman VM, Lukashev AN, et al; Hepatovirus Ecology Consortium. Evolutionary origins of hepatitis A virus in small mammals. Proc Natl Acad Sci U S A. 2015; 112: 15190-5.
12. Gholizadeh O, Akbarzadeh S, Ghazanfari Hashemi M, et al. Hepatitis A: Viral Structure, Classification, Life Cycle, Clinical Symptoms, Diagnosis Error, and Vaccination. Can J Infect Dis Med
Microbiol. 2023; 2023: 4263309.
13. Normann A, Badur S, Önel D, et al. Acute hepatitis A virus infection in Turkey J Med Virol 2008; 80: 785-90.
14. Lanford RE, Walker CM, Lemon SM. Nonhuman Primate Models of Hepatitis A Virus and Hepatitis E Virus Infections. Cold Spring Harb Perspect Med. 2019; 9: a031815.
15. Rivera-Serrano EE, González-López O, Das A, Lemon SM. Cellular entry and uncoating of naked and quasi-enveloped human hepatoviruses. Elife. 2019; 8: e43983.
16. Di Cola G, Fantilli AC, Pisano MB, Ré VE. Foodborne transmission of hepatitis A and hepatitis E viruses: A literature review. Int J Food Microbiol 2021; 338:108986.
17. Abravanel F, Lhomme S, El Costa H, et al. Rabbit Hepatitis E Virus Infections in Humans, France. Emerg Infect Dis. 2017; 23 :1191-1193.
18. Lee GH, Tan BH, Teo EC, et al. Chronic Infection With Camelid Hepatitis E Virus in a Liver Transplant Recipient Who Regularly Consumes Camel Meat and Milk. Gastroenterology. 2016;
150: 355-7.e3.
19. European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu; European Association for the Study of the Liver. EASL Clinical Practice Guidelines on hepatitis E
virus infection. J Hepatol. 2018; 68: 1256-1271.
20. Purdy MA, Drexler JF, Meng XJ, et al. ICTV Virus Taxonomy Profile: Hepeviridae 2022. J Gen Virol. 2022; 103: 10.1099/jgv.0.001778.
21. Himmelsbach K, Bender D, Hildt E. Life cycle and morphogenesis of the hepatitis E virus. Emerg Microb Infect 2018;7:196.
22. Chatziprodromidou IP, Dimitrakopoulou ME, Apostolou T, Katopodi T, Charalambous E, Vantarakis A. Hepatitis A and E in the Mediterranean: A systematic review. Travel Med Infect Dis.
2022; 47: 102283.
23. World Health Organization. Global hepatitis report, 2017. https://www.who.int/publications/i/item/9789241565455. (Erişim 01.04.2024)
24. Colak D, Ogunc D, Gunseren F, Velipasaoglu S, Aktekin MR, Gültekin M. Seroprevalence of antibodies to hepatitis A and E viruses in pediatric age groups in Turkey. Acta Microbiol Immunol
Hung. 2002; 49: 93-7.
25. Yilmaz H, Karakullukcu A, Turan N, et al. Genotypes of hepatitis a virus in Turkey: first report and clinical profile of children infected with sub-genotypes IA and IIIA. BMC Infect Dis 2017;
17: 561.
26. Ceyhan M, Yildirim I, Kurt N, et al. Differences in hepatitis A seroprevalence among geographical regions in Turkey: a need for regional vaccination recommendations. J Viral Hepat. 2008;
15: 69-72.
27. World Health Organization (WHO) Hepatitis E. https://www.who.int/news-room/fact-sheets/detail/hepatitis-e (Erişim 01.04.2024)
28. Kamer N, Bendell R, Legrand-Abravanel F ve et al. Hepatit E. Lancet. 2012; 379 : 2477-2488.
29. Inadomi J M, Bhattacharya R, Hwang J H, and Ko C (eds). Yamada’s Handbook of Gastroenterology. Viral Hepatitis, 5th edn. Oxford: Blackwell Publishing Ltd, 2009.
30. Boccia D, Guthmann JP, Klovstad H, et al. High mortality associated with an outbreak of hepatitis E among displaced persons in Darfur, Sudan. Clin Infect Dis. 2006; 42: 1679-84.
31. Ahmed JA, Moturi E, Spiegel P, et al. Hepatitis E outbreak, Dadaab refugee camp, Kenya, 2012. Emerg Infect Dis. 2013; 19: 1010-2.
32. Aspinall EJ, Couturier E, Faber M, et al; The Country Experts. Hepatitis E virus infection in Europe: surveillance and descriptive epidemiology of confirmed cases, 2005 to 2015. Euro Surveill.
2017; 22: 30561.
33. Ren X, Wu P, Wang L, et al. Changing Epidemiology of Hepatitis A and Hepatitis E Viruses in China, 1990-2014. Emerg Infect Dis. 2017; 23: 276-279.
34. Yaşar O, Karatayli E, Cengiz G, et al. HEV seroprevalence in blood donors in Turkey by two commercial total anti-HEV Ab ELISA kits. J Med Virol. 2019; 91: 2174–2181.
35. Alkan S, Cancan Gürsul N, Önder T. Türkiye Kaynaklı Hepatit E Virus Seroprevelans Çalışmalarının Gözden Geçirilmesi. Dent & Med J – R. 2022; 4: 59-71.
36. Maier K, Gabriel P, Koscielniak E, et al. Human gamma interferon production by cytotoxic T lymphocytes sensitized during hepatitis A virus infection. J Virol. 1988; 62: 3756-63.
37. Pischke S, Hartl J, Pas SD, Lohse AW, Jacobs BC, Van der Eijk AA. Hepatitis E virus: Infection beyond the liver? J Hepatol. 2017 May;66(5):1082-1095.
38. World Health Organization (WHO). Hepatitis A. https://www.who.int/news-room/fact-sheets/detail/hepatitis-a? (Erişim 01.04.2024).
39. Kumar A, Saraswat VA. Hepatitis E and Acute-on-Chronic Liver Failure. J Clin Exp Hepatol. 2013; 3: 225-30.
40. Aggarwal R. Clinical presentation of hepatitis E. Virus Res. 2011; 161: 15-22.
41. Kenfak-Foguena A, Schöni-Affolter F, Bürgisser P, et al. ; Data Center of the Swiss HIV Cohort Study, Lausanne, Switzerland. Hepatitis E Virus seroprevalence and chronic infections in pa-
tients with HIV, Switzerland. Emerg Infect Dis. 2011; 17: 1074-8.
42. Kamar N, Abravanel F, Selves J, et al. Influence of immunosuppressive therapy on the natural history of genotype 3 hepatitis-E virus infection after organ transplantation. Transplantation.
2010; 89: 353-60.
43. Dalton HR, Bendall RP, Keane FE, Tedder RS, Ijaz S. Persistent carriage of hepatitis E virus in patients with HIV infection. N Engl J Med. 2009; 361: 1025-7.
43. Péron JM, Dalton H, Izopet J, Kamar N. Acute autochthonous hepatitis E in western patients with underlying chronic liver disease: a role for ribavirin? J Hepatol. 2011; 54: 1323-4.
44. Cao Y, Bing Z, Guan S, Zhang Z, Wang X. Development of new hepatitis E vaccines. Hum Vaccin Immunother. 2018; 14: 2254-2262.